Robert Ezzell
Corporate Officer/Principal chez ATAI LIFE SCIENCES N.V.
Profil
Robert Ezzell is currently a Senior Director-Regulatory Affairs at ATAI Life Sciences NV since 2021.
Prior to this, he worked as a Director-Product Development at RenaMed Biologics, Inc., a Director-Regulatory Affairs at Glympse Bio, Inc., and an Assistant Professor at Harvard Medical School.
He holds a doctorate degree from the University of California, Berkeley.
Postes actifs de Robert Ezzell
Sociétés | Poste | Début |
---|---|---|
ATAI LIFE SCIENCES N.V. | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de Robert Ezzell
Sociétés | Poste | Fin |
---|---|---|
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Conseiller Juridique Général | - |
Formation de Robert Ezzell
University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ATAI LIFE SCIENCES N.V. | Health Technology |
Entreprise privées | 2 |
---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |